A new drug targets RAS cancer-causing cells in the pancreas, nearly doubling survival rates in clinical trials. Here's how the drug works.

A new daily pill called daraxonrasib is showing promise against advanced pancreatic cancer in a first-in-human trial of 168 patients with RAS mutations.

Women taking the drug tell the BBC it has given them their lives back.

A BREAKTHROUGH jab could turn the clock back on how our immune system ages — and help to tackle cancer and dementia.

A breakthrough targeted therapy, mirvetuximab soravtansine, is offering new hope to women with hard-to-treat ovarian cancer. Studies show it extends survival, slows disease progression, shrinks ...

Immunotherapy wipes out some colorectal tumors without surgery, signaling a major shift toward less invasive treatment.

THOUSANDS of men with prostate cancer are to get ultra high-powered radiotherapy on the NHS for the first time.  The ...

Daraxonrasib was shown to have “landscape-changing” results in extending life expectancy, according to the American Society ...

The FDA could approve the first blood test that can detect multiple cancers, around the end of the year, setting the stage ...

In the study, patients taking the drug lived longer compared to those undergoing chemotherapy. "This study showed that they ...

Breaking news and analysis from time.com. Politics, world news, photos, video, tech reviews, health, science, and ...

Data from a late-stage trial, presented on Sunday, indicate that the treatment, administered six months before and after surgery, substantially increased the chances of eliminating cancer and reduced ...